Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
59.96 EUR | -6.08% | 0.00% | 0.00% |
Jul. 01 | Henry Schein, Inc.(NasdaqGS:HSIC) added to Russell 1000 Dynamic Index | CI |
Jun. 25 | Evercore ISI Adjusts Price Target on Henry Schein to $75 From $79 | MT |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 8.29B | - | ||
-5.77% | 1.35B | D | ||
+9.86% | 1.31B | - | ||
-34.15% | 971M | B+ | ||
-33.75% | 693M | - | - | |
-.--% | 618M | - | - | |
+5.02% | 457M | - | ||
+1.81% | 431M | - | - | |
-38.39% | 272M | - | - | |
-70.53% | 206M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.